Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The independent source for health policy research, polling, and news.
581 - 600 of 757 Results
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN鈥檚 Julie Rovner to discuss the new 鈥淢edicare-for-all鈥 bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN鈥檚 Julie Appleby about the latest 鈥淏ill of the Month鈥 installment.
The progressive proposal adds details to the discussion of this controversial approach to overhauling the nation鈥檚 health system, and Democratic primary candidates will have to be prepared to get more specific.
The Senate Finance Committee grilled executives from seven major drugmakers on Tuesday.
New Mexico is one of several states looking at offering consumers a government-sponsored plan. The proposals would typically have benefits similar to what is available in Medicaid, the state-federal health plan for low-income people.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Tuesday鈥檚 Senate hearing with pharma CEOs will tackle the same issues as the famous Kefauver hearings in 1960.
The 鈥淢edicare鈥揻or-all鈥 debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner for a beginner鈥檚 guide to the next big health policy debate. For 鈥渆xtra credit,鈥 the panelists provide their favorite health policy stories of the week, and as a special Valentine鈥檚 Day bonus, their favorite #HealthPolicyValentines.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN鈥檚 Julie Rovner to discuss these issues and take questions from a live studio audience.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Medicare and Medicaid are fine, but the food safety component of the Food and Drug Administration and bio-threat surveillance done by the Department of Homeland Security are among the public health functions feeling the pinch.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The leaders of California鈥檚 legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats鈥 takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.
Congress approved two bills last month that prohibit provisions keeping pharmacists from telling patients when they can save money by paying the cash price instead of the price negotiated by their insurance plan.
漏 2026 麻豆女优